New: NCI-funded clinical trial search
Mednet Logo

How would you plan your treatment for a locally advanced uterine cancer where there was intraoperative evidence of multiple rectal nodules that are biopsy positive?

She has has p53-abnormal, pMMR clear cell carcinoma that involves both ovaries and has spread superficially along the distal rectum as multiple sub-centimeter nodules, without invading the mucosa or lymph nodes. Her systemic treatment plan will consist of combined chemotherapy and immunotherapy. Given these surgical findings, would you include the entire distal rectum in your pelvic radiation treatment field to ensure adequate coverage of microscopic disease? Would you include the entire distal rectum in your field?
3 Answers
Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network
Answered on

This looks like pelvic peritoneal disease along with ovarian spread. If optimal debulking is done, I will reimage after chemotherapy. If imaging is NED, I would consider pelvic RT for clear-cell histology, but the absolute benefit is not known in this scenario, and no RT is also reasonable. I would ...

Join for free or sign in to see the full answer

Mednet MemberInvited Expert
Radiation Oncology · Allegheny Health Network
Answered on

There are a lot of additional data points that could be helpful:

  • Was there pre-op imaging suggestive of any additional disease elsewhere?
  • Were the nodules biopsied or resected?
  • Were there any other suspicious peritoneal findings intraoperatively?
  • Were washings positive?

Given adnexal and rectal se...

Join for free or sign in to see the full answer

Mednet MemberInvited Expert
Radiation Oncology · Harold C Simmons Comprehensive Cancer Center/UT Southwestern
Answered on

After completion of systemic therapy while the patient is getting immunotherapy I would perform staging imaging and if negative I would treat the entire pelvis and the mesorectum including the distal rectum to the full adjuvant dose of 50 Gy in 25 fractions. The patient would continue immunotherapy ...

Join for free or sign in to see the full answer